The 87 rating InvestorsObserver gives to Viridian Therapeutics Inc (VRDN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 98 percent of stocks in the Biotechnology industry, VRDN’s 87 overall rating means the stock scores better than 87 percent of all stocks.
VRDN has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on VRDN!